PCSK9 Inhibitor: all 21 studies that test it
Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.
- Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS PatientsNot yet recruitingNCT07736313Phase 3
- Aggressive Lipid Lowering Therapy in ICI-Treated MelanomaRecruitingNCT07704918Not applicable
- Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon AdenocarcinomaRecruitingNCT07468630Phase 2
- Very Early PCSK9 Inhibition for Acute Myocardial InfarctionRecruitingNCT07208006Not applicable
- PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular TherapyNot yet recruitingNCT07174375Phase 2/3
- Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot StudyNot yet recruitingNCT07084259Phase 4
- Assessing Coronary Non-Culprit Plaque Early with Start of PCSK9 Inhibitors in Acute Myocardial Infarction (ACCESS-AMI)Not yet recruitingNCT06854523Not applicable
- PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)Not yet recruitingNCT06791031Not applicable
- Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)Not yet recruitingNCT06730802Not applicable
- Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion StrokeRecruitingNCT06649240Not applicable
- Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence TomographyRecruitingNCT06520904Phase 4
- Exploratory Research of PCSK9 Inhibitor on Patency of aAVF After PTA With PCBRecruitingNCT06034691Not applicable
- Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)RecruitingNCT05623995Phase 4
- Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical OutcomeRecruitingNCT05397405Not applicable
- The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic PlaquesRecruitingNCT03753555Phase 4
- CHOlesterol Lowering and Residual Risk in Type 2 DiabetesCompletedNCT04369664Phase 4Results posted
- Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant PatientsActive, not recruitingNCT05537948Phase 4
- Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary SyndromeStatus unknownNCT05298475Phase 4
- Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence TomographyCompletedNCT04851769Phase 4
- Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage StudyStatus unknownNCT04730648Not applicable
- PCSK9 Inhibitors in the Progression of Aortic StenosisStatus unknownNCT03051360Phase 2